1. Home
  2. NEGG vs XBIT Comparison

NEGG vs XBIT Comparison

Compare NEGG & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newegg Commerce Inc.

NEGG

Newegg Commerce Inc.

N/A

Current Price

$12.70

Market Cap

350.3M

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.20

Market Cap

66.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEGG
XBIT
Founded
2001
2005
Country
United States
United States
Employees
714
N/A
Industry
Other Specialty Stores
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
350.3M
66.8M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
NEGG
XBIT
Price
$12.70
$2.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 41.6K
36.5K
Earning Date
08-27-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$30.47
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$12.50
$2.09
52 Week High
$96.29
$3.44

Technical Indicators

Market Signals
Indicator
NEGG
XBIT
Relative Strength Index (RSI) 37.24 47.52
Support Level $12.52 $2.16
Resistance Level $14.98 $2.48
Average True Range (ATR) 0.71 0.04
MACD -0.03 0.01
Stochastic Oscillator 14.44 66.67

Price Performance

Historical Comparison
NEGG
XBIT

About NEGG Newegg Commerce Inc.

Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products, and provides certain third-party logistics services globally. Geographically, it operates in the United States, Canada, and the Rest of the world.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: